Objective: Glycogen synthase kinase 3b (GSK-3b) is an enzyme implicated in neurodevelopmental processes with a broad range of substrates mediating several canonical signaling pathways in the brain. The authors investigated the association of variation in the GSK-3b gene with a series of progressively more complex phenotypes of relevance to schizophrenia, a neurodevelopmental disorder with strong genetic risk. Method: Based on computer predictions, the authors investigated in humans the association of GSK-3b functional variation with 1) GSK-3b mRNA expression from postmortem prefrontal cortex, 2) GSK-3b and b-catenin protein expression from peripheral blood mononuclear cells (PBMCs), 3) prefrontal imaging phenotypes, and 4) diagnosis of schizophrenia. Results: Consistent with predictions, the TT genotype of a single-nucleotide polymorphism in GSK-3b (rs12630592) was associated with reduced GSK-3b mRNA from postmortem prefrontal cortex. Furthermore, this genotype was associated with GSK-3b protein expression and kinase activity, as well as with downstream effects on b-catenin expression in PBMCs. Finally, the TT genotype was associated with attenuated functional MRI prefrontal activity, reduced prefrontal cortical thickness, and diagnosis of schizophrenia. Conclusions: These results suggest that GSK-3b variation is implicated in multiple phenotypes relevant to schizophrenia.

GSK-3beta genetic variation is associated with GSK-3beta expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia

FAZIO, LEONARDO;
2013

Abstract

Objective: Glycogen synthase kinase 3b (GSK-3b) is an enzyme implicated in neurodevelopmental processes with a broad range of substrates mediating several canonical signaling pathways in the brain. The authors investigated the association of variation in the GSK-3b gene with a series of progressively more complex phenotypes of relevance to schizophrenia, a neurodevelopmental disorder with strong genetic risk. Method: Based on computer predictions, the authors investigated in humans the association of GSK-3b functional variation with 1) GSK-3b mRNA expression from postmortem prefrontal cortex, 2) GSK-3b and b-catenin protein expression from peripheral blood mononuclear cells (PBMCs), 3) prefrontal imaging phenotypes, and 4) diagnosis of schizophrenia. Results: Consistent with predictions, the TT genotype of a single-nucleotide polymorphism in GSK-3b (rs12630592) was associated with reduced GSK-3b mRNA from postmortem prefrontal cortex. Furthermore, this genotype was associated with GSK-3b protein expression and kinase activity, as well as with downstream effects on b-catenin expression in PBMCs. Finally, the TT genotype was associated with attenuated functional MRI prefrontal activity, reduced prefrontal cortical thickness, and diagnosis of schizophrenia. Conclusions: These results suggest that GSK-3b variation is implicated in multiple phenotypes relevant to schizophrenia.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/20.500.12572/7807
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
social impact